Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
These formulations became more accessible during the 2022-2024 FDA-declared shortages of brand-name products, when compounding played a larger role in meeting demand
Clinical data supports effectiveness, but coverage decisions rest on insurance cost-containment policies rather than clinical merit
Red flags to watch for: Patches claiming to contain semaglutide or deliver the same dose as Wegovy without a prescription Vague proprietary blends with no clear milligram amounts No company contact info, lot numbers, or manufacturing quality standards Berberine patches marketed as identical to prescription drugs How PatchMD differentiates itself: Transparent ingredient listing with specific amounts Clear labeling that the product does not contain GLP-1 drugs Education-first content encouraging users to work closely with their physician Read supplement facts panels carefully
Endocrinol Metab Clin North Am (2014) 43:4157
FDA approval does not mean the medicine is risk-free for everyone
